Mpox vaccine (2024)
A contract for a vaccine indicated for primary vaccination against smallpox, Mpox and disease caused by vaccinia virus in adults. Delivery of more than 150,000 doses will be required over the initial term, with an option to extend for up to an additional 24 months. Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.
Buyer
UK Health Security Agency
Value
£1
Published
10 Oct 2024
Closes
11 Sept 2024
Procurement details
Source
Contracts Finder
Region
Tower Hamlets
Procurement method
Limited
Category
Goods
Contract starts
11 Sept 2024
Contract ends
31 Dec 2027
CPV classifications
33651600
Vaccines
Lots
Lot default Mpox vaccine (2024)
£1
A contract for a vaccine indicated for primary vaccination against smallpox, Mpox and disease caused by vaccinia virus in adults. Delivery of more than 150,000 doses will be required over the initial term, with an option to extend for up to an additional 24 months. Value - The value has been withheld so as not to prejudice the legitimate commercial interest...
Delivery: United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
10 Oct 2024
Awarded contract notice on Contracts Finder
Award notice · Web page
Award documents CMPHV24306278
Not provided
Award documents CMPHV24306278
ZIP archive
Contains public sector information licensed under the Open Government Licence v3.0.